Codexis Inc. (4QK)
FSX
Closed
Oct 23, 2026
Day's Range
1.1252 wk Range
0.8285Overview - 4QK - Codexis Inc.
Key Statistics
Valuation
Enterprise Value
132.49M
P/E (Trailing)
-2.44
P/E (Forward)
-2.35
PEG Ratio
0.13
Price / Sales (TTM)
1.69
Price / Book
3.79
EV / EBITDA
-7.79
Profitability
Gross Margin
76.45%
Profit Margin
-39.55%
Operating Margin
-75.28%
Return on Assets
-11.73%
Return on Equity
-69.36%
Ownership
Shares Outstanding
91.38M
Float
82.34M
Held by Insiders
7.11%
Held by Institutions
70.15%
Price stats
Beta
2.55
50-Day Avg
1.26
200-Day Avg
1.59
Market Cap - 4QK - Codexis Inc.
Peers - 4QK - Codexis Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 4QKFSXCodexis Inc.133.81MMarket Cap-75.78%52-week change-2.44P/E (Trailing)-39.55%Profit Margin
- ANLFSXAnalog Devices, Inc.166.10BMarket Cap+40.40%52-week change47.41P/E (Trailing)29.78%Profit Margin
- 0QFFSXModerna Inc.75.83BMarket Cap+88.13%52-week change25.27P/E (Trailing)-141.42%Profit Margin
- 1AEFSXargenx SE46.38BMarket Cap+7.13%52-week change36.55P/E (Trailing)32.26%Profit Margin
- 64BFSXAstera Labs, Inc.45.97BMarket Cap+48.68%52-week change176.19P/E (Trailing)30.74%Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt45.90BMarket Cap-5.00%52-week change32.46P/E (Trailing)32.26%Profit Margin
- 42ZFSXRevolution Medicines, Inc.35.79BMarket Cap+70.06%52-week change-28.07P/E (Trailing)0.00%Profit Margin
Profile Summary - 4QK - Codexis Inc.
About
Codexis Inc. is a biotechnology company focused on enzyme engineering and biocatalysis. Codexis develops and commercializes proprietary protein engineering technologies that create tailored enzymes for pharmaceutical manufacturing, RNA synthesis, molecular biology, diagnostics, and other life sciences applications.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
